Capillary Q3 FY26: consol revenue up 16% YoY, 9M PAT jumps to Rs 90 mn

Revenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

CAPILLARY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹612.45

prior close

₹614.20

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.8%-0.3% vs market

Software Products peers, median of 34sector-0.9%-0.3% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.3 pts less than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.0

15m

-0.4

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1-0.8-0.3-0.9-0.3

Next day

-3.0+1.8-4.8+0.3-3.4

-4.4+2.8-7.2+0.6-5.0

-6.3+2.3-8.5-0.0-6.2

-8.1+1.8-9.8+1.2-9.3

-16.1+0.3-16.4-1.5-14.6

-11.2+0.5-11.7-1.2-10.0

15d

-16.4-2.5-13.9-5.8-10.6

-14.6-6.3-8.3-4.1-10.6

-20.4-8.0-12.4-9.0-11.4

-6.9+8.3-15.2-7.6+0.7

UpDownMarket · Nifty Microcap 250Sector · Software Products peers, median of 34Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Capillary Technologies Q3 FY26: consolidated revenue at Rs 1,840 mn (up 16% YoY from Rs 1,590 mn). Nine month consolidated revenue rose 22% to Rs 5,433 mn. Consolidated Q3 PAT at Rs 79.9 mn vs Rs 102.6 mn YoY, while 9M consol PAT grew about 162% to Rs 90.2 mn. Standalone Q3 PAT was Rs 10.5 mn (vs loss Rs 29.4 mn QoQ). Company completed IPO in Nov 2025 raising Rs 3,450 mn fresh funds and got listed on BSE and NSE.

Likely market impact

Strong top-line growth and big jump in 9M consolidated PAT post-IPO signal healthy business momentum for shareholders.